HC Reform Update by Mark Sanna: The nation’s drug makers have eliminated nearly 35,000 positions in the first half of this year, second only to government in cutting jobs, according to a new report by Challenger, Gray and Christmas, a Chicago-based outplacement consulting firm. Still, the industry faces the prospect of more job losses to support the bottom line as patents expire on prominent drugs within the next year.